Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR: Colchicine in Renal Disease
NCT06203977Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Nov 2024
- Primary completion
- Apr 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in chronic kidney disease (CKD), kidney failure (ESRD), sponsored by Hamilton Health Sciences. Started Nov 2024; status: completed.
02
Drugs
colchicine
03
Conditions
chronic kidney disease (CKD)kidney failure (ESRD)
Beyond the preview
Go deeper on NCT06203977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203977.